Effects of laser photocoagulation on corneal neovascularization in rabbits.

J Refract Corneal Surg

Department of Ophthalmology, Catholic University Medical College, Kangnam St Mary's Hospital, Seoul, Korea.

Published: May 1995

Background: Corneal neovascularization is a common clinical entity. Although visual acuity is usually impaired and corneal function compromised, there has been only limited success in the clinical management of this condition. We evaluated the efficacy of laser photocoagulation of neovascularization in the rabbit cornea.

Methods: New vessel formation was provoked by the placement of sutures in the corneas. Rose bengal was injected intravenously and new vessels in the upper part of the corneas were treated with an argon laser. The lower halves were used as controls. Eighteen rabbits were divided into 2 groups. In group A neovascularization was treated 28 days after suture removal, when corneal inflammation had regressed. In group B treatment was performed 3 days after suture removal, when the cornea still exhibited marked inflammation. Postoperatively, the corneas were studied by slit-lamp microscopy, fluorescein angiography, and light, as well as electron microscopy.

Results: In group A, treatment led to the immediate occlusion of the vessels and to their gradual disappearance during the course of 3 months. In group B, no occlusion was seen during the 3-month follow-up period. The main histologic findings in the occluded vessels were endothelial cell disruption and degeneration, and the formation of clots.

Conclusion: Our results suggest that argon laser photocoagulation using rose bengal is an effective method of occluding corneal new vessels, providing there is no corneal inflammation at the time of treatment.

Download full-text PDF

Source

Publication Analysis

Top Keywords

laser photocoagulation
12
corneal neovascularization
8
rose bengal
8
argon laser
8
days suture
8
suture removal
8
corneal inflammation
8
group treatment
8
corneal
6
effects laser
4

Similar Publications

Background: Non-proliferative and proliferative diabetic retinopathy are common complications of diabetes and a major cause of sight loss. Anti-vascular endothelial growth factor drugs represent a treatment option for people with diabetic retinopathy and are routinely used to treat various other eye conditions. However, anti-vascular endothelial growth factor drugs are expensive relative to current care options, and it is unclear whether this additional cost is justified when the immediate risk of vision loss is lower compared to patients with more aggressive ophthalmological conditions.

View Article and Find Full Text PDF

Purpose: We report a case of Eales disease in Inuit and reflect on advances in telemedicine and treatment of retinal disease since the first report of Eales' disease in Greenlandic Inuit was published.

Patients And Methods: A 41-year-old Inuit female complaining of blurred vision was referred to our eye department. There had been no sign of diabetic retinopathy during diabetic eye screening and the patient had been treated for tuberculosis in 2010.

View Article and Find Full Text PDF

Clinical features, diagnosis, management, and prognosis of circumscribed choroidal hemangioma.

Surv Ophthalmol

January 2025

Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730, China; Key Lab of Ocular Fundus Diseases, Chinese Academy of Medical Sciences, Beijing 100730, China. Electronic address:

Because of its benign nature and rarity, circumscribed choroidal hemangioma (CCH) often receives limited attention, leading to a high rate of misdiagnosis and a lack of standardized treatment protocols. We provide a thorough clarification of the demographics, clinical features, diagnosis, management, and prognosis of CCH. We conducted a systematic search of the PubMed, EMBASE, and Ovid databases up to December, 2023, to identify relevant studies.

View Article and Find Full Text PDF

Branch retinal vein occlusion (BRVO) is a common retinal vascular condition and a significant contributor to vision loss worldwide, particularly in middle-aged and elderly populations. This review synthesizes current knowledge on the epidemiology, pathogenesis, and clinical features of BRVO, alongside recent advancements in diagnostic and therapeutic strategies. BRVO is approximately four times more prevalent than central retinal vein occlusion (CRVO) and often leads to significant vision impairment.

View Article and Find Full Text PDF

Background: The principal objective of our study is to evaluate the characteristics of babies with type 1 ROP, screening practices and treatment trends in a tertiary care centre in Pakistan.

Methods: This prospective study at Mayo Hospital, Lahore (July 2022-July 2024), included 89 preterm infants with type 1 ROP, selected using non-probability sampling. Infants were categorized based on international (GA < 32weeks or BW < 1500 g) and local screening criteria (GA < 35 weeks or BW < 2000 g), and treatment outcomes were evaluated across three groups: Anti-VEGF, combination therapy (Anti-VEGF followed by laser), and laser therapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!